Galileo Surgical Innovation's product pipeline consists of a group of devices for addressing the postoperative staple line leak problems of the surgical staplers for internal use complementing the Copernicus Surgical's Tissue Probe line of products for addressing the intraoperative problems of technical nature.
Solid Scientific Foundation
Each product in Galileo Surgical Innovation's product pipeline is highly engineered to effectively function under the physiological motion of target organ that is known to be a primary cause of staple line leak even from a staple line verified to be normally formed during surgery.
Intellectual Property Pipeline
Galileo Surgical Innovation's intellectual property portfolio includes patents, issued or otherwise in advanced stage of development, and trade secrets and knowledge base accumulated over the years
Patents (Grouped by Subject)
Tissue Probe Device
5 U.S. patents issued
TP-Overload Protector: Prevents stapler malfunction/failure due to overly thick tissue
TP-Discriminator: Assess hemostasis performance of a selected staple & Prevent stapler overloading
TP-Comparator: Determine tissue thickness at a given compression level
TP-Analyzer: Determine compressive elastic property of tissue at a given thickness
Stapling of Thick (> 2.3 mm) Tissue
Specialty end effector #1 for accommodating taller than usual staple
Specialty end effector #2 for accommodating taller than usual staple
Device capable of controlling tissue movement during staple firing
Stapler instrument for staple with formed height up to 3 mm
Stapling to a Given Compression
A first stapler instrument with a specialty staple driver mechanism
Topical Reinforcement of Staple Line
2 U.S. patents issued
A second stapler instrument with a specialty staple driver mechanism
Surgical Brace Device
Staple Line Inspection
Device for measurement of compressive mechanical property of staple line
Device for measurement of tensile mechanical property of staple line
Advanced Stapling Devices and Methods
Device for tissue manipulation and stapling with reduced compressive stress on tissue
Trade Secrets & Knowledge Base
(1) Novel regulatory framework (included in Safer Technologies Program by FDA in 2022)
(2) Novel organ specific, staple designs and standard set of staple reloads based on the mechanical property of organ (e.g., stomach, lung, intestine)
(3) Novel stapling method and staple layout strategy based on the physiological motion of organ (e.g., breathing, digestive or peristaltic motion) and the content of organ (e.g., lubricious air in the lung or viscous digestive medium in the stomach and intestine)
